About OpMap

What we are building, and who we are building it with.

What we do

Catheter ablation for atrial fibrillation is one of the most widely performed procedures in cardiac electrophysiology, and outcomes still vary between patients and between operators.

OpMap was founded by physicians and engineers who work in this field. We are developing software that processes intracardiac signals recorded during electrophysiology procedures. The work is in research and development, and we are building it together with clinicians rather than for them.

Our software is at the research and development stage. It is not approved or cleared for clinical use in any jurisdiction, in Japan or overseas. Nothing on this site is intended as advertising for a medical device.

Who we would like to meet

  • Business development teams at medical device companies and distributors in the arrhythmia / EP field
  • Electrophysiologists and centers interested in clinical evaluation
  • Investors with an interest in medical software from Japan
  • CXO candidates in regulatory affairs, engineering, and business development

Company

NameOpMap Inc. (OpMap株式会社)
FoundedApril 2026
LocationBunkyo-ku, Tokyo, Japan
BusinessResearch and development of software for cardiac electrophysiology